3-溴苯酰乙腈 | 70591-86-5

• 物质功能分类: 化学试剂 - 有机试剂 - 氰化物/腈
• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 3-溴苯酰乙腈
• 中文别名: 3-溴苯甲酰乙腈
• 英文名称: 3-(3-bromophenyl)-3-oxopropanenitrile
• 英文别名: 3-bromobenzoylacetonitrile
• CAS: 70591-86-5
• 化学式: C₉H₆BrNO
• mdl: MFCD02260778
• 分子量: 224.057
• InChiKey: VBFNSHGLANEMRM-UHFFFAOYSA-N

物化性质

• 熔点：
  93-95°C
• 沸点：
  364.8±27.0 °C(Predicted)
• 密度：
  1.523±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.111
• 拓扑面积：
  40.9
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2926909090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  室温且干燥

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Bromobenzoylacetonitrile
Synonyms: 3-(3-Bromophenyl)-3-oxopropanenitrile

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Bromobenzoylacetonitrile
CAS number: 70591-86-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H6BrNO
Molecular weight: 224.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-溴苯酰乙腈 在 RuCl2(1,3-dimesityl-imidazolidin-2-yl)(PCy3)(=CHPh) 、 copper(l) iodide 、 高氯酸 、 lithium hydroxide monohydrate 、 palladium 10% on activated carbon 、 (1R,2R)-(-)-N,N'-二甲基-1,2-环己二胺 、 水 、 氢气 、 双(三甲基硅烷基)氨基钾 、 potassium carbonate 、 戴斯-马丁氧化剂 、 对甲苯磺酸 、 一水合肼 、 N,N-二甲基苯胺 、 N,N-二异丙基乙胺 、 (R)-2-甲基-CBS-恶唑硼烷 、 三氯氧磷 、 儿萘酚硼烷 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 、 二氯甲烷 、 邻二甲苯 、 1,2-二氯乙烷 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 78.84h， 生成 (2S)-tert-butoxy[4,25-dimethyl-24-oxa-1,5,7,8,15,30-hexaazahexacyclo[23.2.2.1^6,9.1^10,14.1^15,18.0^2,7]dotriaconta-2,4,6(32),8,10(31),11,13,16,18(30)-nonaen-3-yl]acetic acid
  参考文献：
  名称：

  [EN] PYRAZOLOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
  [FR] MACROCYCLES DE PYRAZOLOPYRIMIDINE UTILISÉS EN TANT QU'INHIBITEURS DE LA RÉPLICATION DU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE

  摘要：

  该公开涉及到一种I式化合物，包括用于治疗人类免疫缺陷病毒（HIV）感染的组合物和方法。该公开提供了HIV的新型抑制剂，包含这些化合物的药物组合物，以及在治疗HIV感染中使用这些化合物的方法。

  公开号：

  WO2015123182A1
• 作为产物：
  描述：

  3-(3-bromophenyl)-3-chloroprop-2-enal 在 ammonium hydroxide 、 碘 、 sodium hydroxide 作用下， 以 二氯甲烷 、 水 、 二甲基亚砜 为溶剂， 反应 0.75h， 生成 3-溴苯酰乙腈
  参考文献：
  名称：

  致命的KCN和昂贵的无金属轨道，使用温和的反应条件即可获得β-酮腈

  摘要：

  摘要 已经描述了使用温和的反应条件，使用经济上良性的碘，氨水和氢氧化钠溶液从易于获得的3-氯丙烯一锅合成β-乙腈。该报告提出了一种便捷，廉价，无毒无害，环保的β-乙腈方法。

  DOI：

  10.1080/00397911.2021.1910846

文献信息

• Efficient Approach to Amide Bond Formation with Nitriles and Peroxides: One-Pot Access to Boronated β-Ketoamides
  作者：Babasaheb Sopan Gore、Gopal Chandru Senadi、Amol Milind Garkhedkar、Jeh-Jeng Wang

  DOI：10.1002/adsc.201700532

  日期：2017.9.4

  An efficient, mild and practical approach for the synthesis of amides from nitriles and peroxides is reported in the presence of boron trifluoride ethereate. In this protocol, we utilized peroxides as C1 synthons for the amidation reaction. Also, we successfully prepared boron‐containing β‐ketoamides in a one‐pot assembly from β‐ketonitriles. A variety of functional groups were tolerated in moderate

  据报道，在三氟化硼醚化物存在下，由腈和过氧化物合成酰胺的有效，温和和实用的方法。在该方案中，我们将过氧化物用作酰胺化反应的C 1合成子。另外，我们还成功地从β-乙腈一锅中制备了含硼的β-酮酰胺。中等至良好的产量可耐受多种官能团。自由基抑制研究表明，反应是通过非自由基途径进行的。
• [EN] INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION<br/>[FR] INHIBITEURS DE RÉPLICATION DU VIRUS D'IMMUNODÉFICIENCE HUMAINE
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2014028384A1

  公开（公告）日：2014-02-20

  The disclosure generally relates to compounds of formula (I), including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.

  该公开涉及到式(I)的化合物，包括用于治疗人类免疫缺陷病毒（HIV）感染的组合物和方法。该公开提供了HIV的新型抑制剂，包含这些化合物的药物组合物，以及使用这些化合物治疗HIV感染的方法。
• [EN] PYRAZOLOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION<br/>[FR] MACROCYCLES DE PYRAZOLOPYRIMIDINE UTILES EN TANT QU'INHIBITEURS DE LA RÉPLICATION DU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2015126376A1

  公开（公告）日：2015-08-27

  The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.

  该披露通常涉及到I式化合物，包括用于治疗人类免疫缺陷病毒（HIV）感染的组合物和方法。该披露提供了HIV的新型抑制剂，含有这些化合物的药物组合物，以及在治疗HIV感染中使用这些化合物的方法。
• [EN] CYANO-SUBSTITUTED HETEROCYCLES WITH ACTIVITY AS INHIBITORS OF USP30<br/>[FR] HÉTÉROCYCLES CYANO-SUBSTITUÉS PRÉSENTANT UNE ACTIVITÉ EN TANT QU'INHIBITEURS DE L'USP30
  申请人：MISSION THERAPEUTICS LTD

  公开号：WO2018065768A1

  公开（公告）日：2018-04-12

  The present invention relates to cyano-substituted-heterocycles of Formula (I) with activity as inhibitors of deubiquitilating enzymes, in particular, ubiquitin C-terminal hydrolase 30 or ubiquitin specific peptidase 30 (USP30), having utility in a variety of therapeutic areas including cancer and conditions involving mitochondrial dysfunction. (Formula (I))

  本发明涉及具有抑制去泛素化酶活性的Formula (I)的氰基取代杂环化合物，特别是泛素C-末端水解酶30或泛素特异性肽酶30（USP30），在包括癌症和涉及线粒体功能障碍等各种治疗领域中具有用途。（Formula (I)）
• Formal [3+2] Annulation of Copper‐Allenylidenes with 3‐Oxo‐3‐Arylpropanenitriles: Synthesis of Tetrasubstituted Furans
  作者：De Zhong、Feng Jiang、Siyong Shen、Lan Wang、Wei Wang、Yongjun Wu、Yumei Xiao、Hongchao Guo

  DOI：10.1002/adsc.202000929

  日期：2020.11.18

  The copper‐catalyzed decarboxylative [3+2] annulation of ethynyl benzoxazinanones with 3‐oxo‐3‐arylpropanenitriles has been developed, producing tetrasubstituted furan derivatives in moderate to high yield. This reaction was generally compatible with a wide range of substrates. Notably, the intermediate copper‐allenylidenes worked as a C2 synthon in the cycloaddition reaction.

  已开发出铜催化的乙炔基苯并恶嗪酮与3-氧代-3-芳基丙腈的[3 + 2]环化反应，可中等至高收率生产四取代呋喃衍生物。该反应通常与多种底物相容。值得注意的是，中间体铜-亚烯基铜在环加成反应中充当C2合成子。